Most Recent

image: Antibiotic Bouncer

Antibiotic Bouncer

By | March 1, 2013

Contrary to previous assumptions that macrolide antibiotics completely block the exit tunnel of ribosomes, new evidence shows that some peptides are allowed to pass.

0 Comments

image: Biology Hacklabs

Biology Hacklabs

By | March 1, 2013

Fueled by donations, sweat, and occasional dumpster diving, community laboratories for DIY biologists are cropping up around the country.

2 Comments

image: Buying Cell-Culture Products

Buying Cell-Culture Products

By | March 1, 2013

A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.

0 Comments

image: Contributors

Contributors

By | March 1, 2013

Meet some of the people featured in the March 2013 issue of The Scientist.

0 Comments

image: Crack Control

Crack Control

By | March 1, 2013

Nanoscale cracks in bone dissipate energy to protect against fracture, a process that appears to be regulated by the interaction of two proteins.

0 Comments

image: Set It and Forget It

Set It and Forget It

By | March 1, 2013

A tour of three systems for automating cell culture

0 Comments

image: Sleep Protection

Sleep Protection

By | March 1, 2013

Inducing certain brain patterns extends non-REM sleep in mice.

0 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

During development, communication between organs determines their relative final size.

2 Comments

image: Synthetic Peptide Fools Immune System

Synthetic Peptide Fools Immune System

By | February 21, 2013

Researchers have created a molecule that helps nanoparticles evade immune attack and could improve drug delivery.  

3 Comments

image: Lucrative Prize for Life Scientists

Lucrative Prize for Life Scientists

By | February 21, 2013

Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech